Do you want to read an article? Please log in or register.
DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation and Practice in DLBCL
Lymphoma
Related content
SPECIAL REPORT
Genitourinary Cancer
EMBARK: Impact of Enzalutamide Plus ADT on Clinical Practice in Biochemically Recurrent Prostate Cancer
EHA/ICML 2025
Lymphoma
SAKK 38/19: PET/ctDNA-guided approach is feasible for treatment allocation in frontline DLBCL
ELCC 2025
Lung, Respiratory and Thoracic Cancer
Tepmetko®: Consistent long-term data and insights from clinical practice
Further Publications
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology
Virchows Arch
Christinat Y, Hamelin B, Alborelli I, Angelino P, Barbié V, Bisig B, Dawson H, Frattini M, Grob T, Jochum W, Nienhold R, McKee T, Matter M, Missiaglia E, Molinari F, Rothschild S, Sobottka-Brillout AB, Vassella E, Zoche M, Mertz KD
doi: 10.1007/s00428-024-03951-0
Gynecologic Cancer
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
★ 3
Recommended and commented by
Dr Andreas Müller, Faculty Member
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Lancet Oncol
Post CCB, de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Leary A, Ottevanger PB, McCormack M, Khaw P, D'Amico R, Fyles A, Chargari C, Kitchener HC, Do V, Lissoni A, Provencher D, Genestie C, Nijman HW, Whitmarsh K, Jürgenliemk-Schulz IM, Feeney A, Lutgens LCHW, Bouma J, Leon-Castillo A, Nout RA, Putter H, Bosse T, Creutzberg CL
doi: 10.1016/S1470-2045(25)00379-1
Lung, Respiratory and Thoracic Cancer
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer
Lung Cancer
Sun F, Banwait MK, Singhal S, Herrmann A, Piotrowska Z, Yun K, Bazhenova L, Ullah AT, Guo EW, Wakelee HA, Neal JW, Das MS, Ramchandran KJ, Roy M, Diehn M, Myall NJ
doi: 10.1016/j.lungcan.2025.108747
EHA 2025
Leukemia
Blinatumomab led to high remission and MRD negativity rates in routine clinical practice for adult Ph-negative B-cell ALL
Leukemia
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials
Lancet Haematol
Potter N, Jovanovic J, Ivey A, Othman J, Thomas A, Gilkes A, Runglall M, Kanda A, Thomas I, Johnson S, Canham J, Villiers W, Knapper S, Khwaja A, McMullin MF, Cavenagh J, Overgaard UM, Clark RE, Solomon E, Freeman SD, Hills R, Burnett A, Russell N, Dillon R, UK AML Research Network
doi: 10.1016/S2352-3026(25)00037-7
Further Publications
Use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline
EClinicalMedicine
Phillips R, Fisher BT, Ladas EJ, Patel P, Robinson PD, Dupuis LL, Ammann RA, Beauchemin MP, Carlesse F, Castagnola E, Davis BL, Efremov K, Elgarten CW, Groll AH, Haeusler GM, Koenig C, Morris A, Santolaya ME, Spinelli D, Tissing WJE, Wolf J, Sung L, Lehrnbecher T
doi: 10.1016/j.eclinm.2025.103093